World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
22285
World Ranking
14294
National Ranking
596

Ladan Fazli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ladan Fazli sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 682 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ladan Fazli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ladan Fazli sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ladan Fazli is affiliated with the University of British Columbia in Canada, focusing their research primarily on medical and biochemical fields. Their work spans medicine, biochemistry, genetics, and molecular biology, with a notable concentration on prostate cancer treatment and research. Fazli's publications demonstrate an extensive engagement with molecular biology and oncology subfields, exploring complex biological pathways and therapeutic strategies.

Their research topics include:

  • Prostate Cancer Treatment and Research
  • PARP inhibition in cancer therapy
  • Prostate Cancer Diagnosis and Treatment
  • Ubiquitin and proteasome pathways
  • RNA Research and Splicing
  • Cancer, Lipids, and Metabolism
  • Cancer, Hypoxia, and Metabolism

Frequent publication venues for Ladan Fazli include:

  • Cancer Research
  • Oncogene
  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nucleic Acids Research

Their recent papers showcase diverse contributions to cancer research and molecular biology:

  • Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer, 2021, Nature Communications
  • An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer, 2021, Nature Cell Biology
  • LIN28B promotes the development of neuroendocrine prostate cancer, 2020, Journal of Clinical Investigation
  • CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer, 2023, Nature Communications
  • A PRC2-independent function for EZH2 in regulating rRNA 2'-O methylation and IRES-dependent translation, 2021, Nature Cell Biology

Ladan Fazli has collaborated frequently with other researchers, indicating a sustained network of co-authorship in their field. Their frequent co-authors include:

  • Martin Gleave
  • Sonia H.Y. Kung
  • Xuesen Dong
  • Neetu Saxena
  • Yuzhuo Wang

Best Publications

  • Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

    Meritxell Gironella;Mylène Seux;Min-Jue Xie;Carla Cano

  • The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

    Charles E Massie;Andy Lynch;Antonio Ramos-Montoya;Joan Boren

  • Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

    Elahe A. Mostaghel;Stephanie T. Page;Daniel W. Lin;Ladan Fazli

  • Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance

    Hiroshi Tanaka;Evelyn Kono;Chau P Tran;Hideyo Miyazaki

  • Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer

    Palma Rocchi;Alan So;Satoko Kojima;Maxim Signaevsky

  • The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.

    Jennifer L Bishop;Daksh Thaper;Daksh Thaper;Sepideh Vahid;Sepideh Vahid;Alastair Davies

  • High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development

    Dong Lin;Alexander W. Wyatt;Hui Xue;Yuwei Wang

  • Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.

    Qian Wang;Qian Wang;Rae Anne Hardie;Rae Anne Hardie;Andrew J. Hoy;Michelle Van Geldermalsen;Michelle Van Geldermalsen

  • Regulation of tumor angiogenesis by integrin-linked kinase (ILK)

    Clara Tan;Severine Cruet-Hennequart;Armelle Troussard;Ladan Fazli

  • A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer

    Kim N. Chi;Elizabeth Eisenhauer;Ladan Fazli;Edward C. Jones

  • Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.

    Amina Zoubeidi;Anousheh Zardan;Eliana Beraldi;Ladan Fazli

  • Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

    Ashish B Rajput;Melinda A Miller;Alessandro De Luca;Niki Boyd

  • Insulin receptor expression by human prostate cancers

    Michael E. Cox;Martin E. Gleave;Mahvash Zakikhani;Robert H. Bell

  • The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

    Shusuke Akamatsu;Alexander W. Wyatt;Dong Lin;Summer Lysakowski

  • Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein

    Ali Salanti;Thomas M Clausen;Mette Ø Agerbæk;Nader Al Nakouzi;Nader Al Nakouzi

  • The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells.

    Yingqiu Xie;Kexin Xu;Douglas E. Linn;Xi Yang

  • Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer.

    Masaki Shiota;Jennifer L. Bishop;Ka Mun Nip;Anousheh Zardan

  • Increased Insulin-Like Growth Factor I Receptor Expression and Signaling Are Components of Androgen-Independent Progression in a Lineage-Derived Prostate Cancer Progression Model

    Sandra L. Krueckl;Robert A. Sikes;N. Magnus Edlund;Robert H. Bell

  • Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.

    Palma Rocchi;Eliana Beraldi;Susan Ettinger;Ladan Fazli

  • Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

    Liesel M FitzGerald;Ilir Agalliu;Ilir Agalliu;Karynn Johnson;Melinda A Miller

Frequent Co-Authors

Martin E. Gleave
Martin E. Gleave University of British Columbia
Amina Zoubeidi
Amina Zoubeidi University of British Columbia
Yuzhuo Wang
Yuzhuo Wang University of British Columbia
Colleen C. Nelson
Colleen C. Nelson Queensland University of Technology
Colin Collins
Colin Collins University of British Columbia
Alexander W. Wyatt
Alexander W. Wyatt University of British Columbia
Kim N. Chi
Kim N. Chi BC Cancer Agency
Peter S. Nelson
Peter S. Nelson Fred Hutchinson Cancer Research Center
Himisha Beltran
Himisha Beltran Harvard University
Peter McL. Black
Peter McL. Black University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Advancing your medical education or starting a healthcare career is more flexible than ever due to online learning. For registered nurses who want to earn a bachelor’s degree without on-site requirements, an rn to bsn online with no clinicals program allows you to study remotely and streamline your transition to higher roles.

If you are aiming for leadership or advanced clinical practice, consider enrolling in the shortest dnp program online or explore online dnp programs without clinicals. These options provide more flexibility, helping you earn your Doctor of Nursing Practice degree quickly or with reduced in-person requirements.

Those looking for an entry-level pathway can opt for a 6 month lpn program online, getting you ready for practical nursing in less time. All these options offer diverse career pathways and make medical education accessible, even for busy individuals balancing work and family.

Best Scientists Citing Ladan Fazli

Trending Scientists

Recently Published Articles